Source: International Congress 2018 – Biomarkers for evaluating COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Yakar (Istanbul, Turkey), A. Kanbay (Istanbul, Turkey), E. Ceylan (Istanbul, Turkey). Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients?. 1076

Member's Comments

No comment yet.

Related content which might interest you: Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients? Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 LSC - 2019 - Assessment of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio as biomarkers of steroid resistance in patients with COPD Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019 Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 The impact of high eosinophil count on hospitalizations in COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018 An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity? Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 The eosinophil cationic protein/eosinophil count ratio as a marker of asthma in children Source: Eur Respir J 2002; 20: Suppl. 38, 114s Year: 2002 Changes in eosinophil count and C reactive protein following treatment with mebendazole in patients with Toxocara-associated asthma Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations Source: International Congress 2017 – COPD and weaning Year: 2017 Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of COPD. Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Definition of COPD phenotype depending on eosinophil count Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Minimal effect of inhaled corticosteroids (ICS) on blood eosinophil count in steroid-naïve COPD patients Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study> Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Lymphocyte-to-segmentonuclear neutrophil ratio in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007